Skip to main content

Tweets

FAST trial, MMF vs MTX at the Review Course today Overall a big win for MTX, powered for noninferiority (bc people loved MMF) but looks like MTX won the day w/10% difference in outcomes Take home: MTX FTW per usual @RheumNow #ACR23 #ReviewCourse https://t.co/lY1V6S7X3d
Mike Putman @EBRheum ( View Tweet )
2 years 3 months ago
New clinical skill to use in the clinic. Auscultate at the TMJ for crepitus and measure the maximal incisal opening in JIA, Sadun R, #ACR23 @RheumNow https://t.co/8koZRCZYoP
Dr. Antoni Chan ( View Tweet )
2 years 3 months ago
OA and Syncope OA patient on NSAIDs presents with a peptic ulcer and GI Bleed. https://t.co/ezMbqgAB0Q https://t.co/iutdfUAPv2
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Hey #ACR23! Need a theme song for rheumatology? Because #Rheum makes your hands clap! https://t.co/vKYOH8zdIv @chroniceileen @realcc @ACRheum @ACRSimpleTasks #RheumTwitter @CRASCRRheum @RheumNow @rheumpatient @RNSociety @ArthritisFdn @VersusArthritis @exerciseworks #arthritis

Alberta Rheumatology @RheumAb ( View Tweet )

2 years 3 months ago
Keeping the eyes 👀 on the target. Early start to the day with the ACR review course on the eye 👁️ in rheumatic disease. Causes of uveitis #ACR23 @RheumNow https://t.co/g5y5Vs01RX
Dr. Antoni Chan ( View Tweet )
2 years 3 months ago
ID testing for pts with inflammatory eye disease: syphilis, TB, Lyme (where appropriate). Low yield is toxoplasma, toxocara and viral dz - Dr L Kopplin #ACRReview @RheumNow #ACR23 https://t.co/UyQ8Bc2cEy
TheDaoIndex @KDAO2011 ( View Tweet )
2 years 3 months ago
Super fun meeting with fellows for the annual FIT session yesterday! Thanks to everyone who came to my table for the expensive FedEx'ed handouts 😂 Here's a link to a PDF & pics if anyone is interested in the handout! @RheumNow #ACR23 https://t.co/kh7sOh2BWj https://t.co/DoEZzHSaAp
Mike Putman @EBRheum ( View Tweet )
2 years 3 months ago
Join us tomorrow! We’ll be hosting a LIVE #ACR23 recap. https://t.co/DxdsaPgRfC
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Join us tonight for our first daily #ACR23 recap! LIVE! https://t.co/jIfrqQXxdY
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Rheumatoid Synovium Characterized by Six Cell Type Phenotypes Could CTAPs known disease features or more effective future therapies? https://t.co/mcbNAO7lAQ https://t.co/wiOW8Xq0mI
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
ACR convergence highlights by the awesome, i mean very awesome team @RheumNow Sunday to Thursday with recap Friday 🤓 i am stocking every one😂 https://t.co/WahAoH7MCM Biologic / target synthetic induced None melanoma skin cancer? Disease induced or medication induced ?

Nouf Al hemmadi ( View Tweet )

2 years 3 months ago
RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Bristol Myers Squibb and UCB. All content is chosen by RheumNow & its faculty.

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago
×